Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.36 USD | -4.23% | -9.42% | -32.80% |
May. 13 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
May. 09 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
Sales 2024 * | 5.3M 6.71M | Sales 2025 * | 75.71M 95.92M | Capitalization | 854M 1.08B |
---|---|---|---|---|---|
Net income 2024 * | -104M -132M | Net income 2025 * | -65M -82.35M | EV / Sales 2024 * | 126 x |
Net cash position 2024 * | 184M 233M | Net cash position 2025 * | 146M 185M | EV / Sales 2025 * | 9.34 x |
P/E ratio 2024 * |
-14.1
x | P/E ratio 2025 * |
-33.7
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.42% |
Latest transcript on Verona Pharma plc
1 day | -4.23% | ||
1 week | -9.42% | ||
Current month | -13.53% | ||
1 month | -17.53% | ||
3 months | -22.33% | ||
6 months | -2.41% | ||
Current year | -32.80% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 20-01-31 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 20-02-29 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 16-06-16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 16-09-11 |
David Ebsworth
CHM | Chairman | 69 | 14-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 13.36 | -4.23% | 721,532 |
24-05-15 | 13.95 | +0.50% | 399,990 |
24-05-14 | 13.88 | 0.00% | 580,253 |
24-05-13 | 13.88 | -6.53% | 914,118 |
24-05-10 | 14.85 | +0.68% | 762,317 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.80% | 1.08B | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.44% | 22.28B | |
-11.90% | 22.41B | |
-4.50% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- VRNA Stock